InflaRx (IFRX) Intangibles (2016 - 2026)
InflaRx (IFRX) posted Intangibles of $53382.5 for Q1 2026, up 8.53% sequentially from $49186.7 in Q4 2025, and down 6.26% YoY from $56944.8 in Q1 2025.
InflaRx (IFRX) Intangibles (2016 - 2026) Analysis & Trends
InflaRx has reported Intangibles for 11 years, with the latest figure at $53382.5 in Q1 2026.
- Quarterly Intangibles fell 6.26% year-over-year to $53382.5 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $53382.5 (down 6.26% YoY) and the FY2025 annual result came in at $47740.2, down 13.14% from the prior year.
- Intangibles grew to $53382.5 in Q1 2026 per IFRX's latest filing, from $49186.7 in the prior quarter.
- Over five years, Intangibles peaked at $798462.5 in Q4 2023 and troughed at $48136.1 in Q3 2024.
- A 5-year average of $171076.5 and a median of $56944.8 in 2025 frame the typical range for Intangibles.
- The sharpest annual moves came in 2024 and 2025: Intangibles sank 93.2% in 2024, then increased 17.36% in 2025.
- Over 5 years, Intangibles stood at $737893.9 in 2022, then gained by 8.21% to $798462.5 in 2023, then tumbled by 93.2% to $54264.3 in 2024, then retreated by 9.36% to $49186.7 in 2025, then increased by 8.53% to $53382.5 in 2026.
- According to Business Quant data, Intangibles over the past three periods registered $53382.5, $49186.7, and $53988.1 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | InflaRx | 140.30 Mn | -43.96 Mn | 2.74 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53,382.49 |
| Dec 31, 2025 | 49,186.66 |
| Sep 30, 2025 | 53,988.13 |
| Jun 30, 2025 | 56,717.97 |
| Mar 31, 2025 | 56,944.82 |
| Dec 31, 2024 | 54,264.34 |
| Sep 30, 2024 | 48,136.06 |
| Jun 30, 2024 | 48,326.41 |
| Mar 31, 2024 | 56,648.33 |
| Dec 31, 2023 | 798,462.54 |
| Sep 30, 2023 | 72,646.00 |
| Jun 30, 2023 | 98,862.36 |
| Mar 31, 2023 | 123,270.09 |
| Dec 31, 2022 | 737,893.91 |
| Sep 30, 2022 | 164,311.41 |
| Jun 30, 2022 | 199,772.22 |
| Mar 31, 2022 | 235,486.66 |
| Dec 31, 2021 | 824,736.71 |
| Sep 30, 2021 | 309,729.20 |
| Jun 30, 2021 | 351,609.93 |